Lobe Sciences Ltd. (LOBE.CN)
CAD 0.02
(-42.86%)
CAD 0.02
(-42.86%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.35 Million CAD | -345.71% |
| 2022 | 1.36 Million CAD | -80.03% |
| 2021 | 6.84 Million CAD | 379.2% |
| 2020 | -2.45 Million CAD | 44.35% |
| 2019 | -4.4 Million CAD | -2869.32% |
| 2018 | -148.4 Thousand CAD | -185.72% |
| 2017 | -51.93 Thousand CAD | -13.45% |
| 2016 | -45.78 Thousand CAD | 26.2% |
| 2015 | -62.03 Thousand CAD | 42.82% |
| 2014 | -108.49 Thousand CAD | 20.87% |
| 2013 | -137.11 Thousand CAD | -45.12% |
| 2012 | -94.48 Thousand CAD | -3.83% |
| 2011 | -91 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -551.34 Thousand CAD | -716.8% |
| 2024 Q3 | -590.36 Thousand CAD | -0.94% |
| 2024 Q2 | -584.84 Thousand CAD | -6.08% |
| 2023 FY | -3.35 Million CAD | -345.71% |
| 2023 Q1 | -2.23 Million CAD | -319.7% |
| 2023 Q3 | -358.6 Thousand CAD | 63.56% |
| 2023 Q4 | -67.5 Thousand CAD | 81.18% |
| 2023 Q2 | -984.19 Thousand CAD | 56.02% |
| 2022 Q3 | 1.25 Million CAD | -59.95% |
| 2022 FY | 1.36 Million CAD | -80.03% |
| 2022 Q4 | 1.01 Million CAD | -18.87% |
| 2022 Q1 | 2.29 Million CAD | 274.91% |
| 2022 Q2 | 3.13 Million CAD | 36.85% |
| 2021 FY | 6.84 Million CAD | 379.2% |
| 2021 Q2 | -2.5 Million CAD | -100.39% |
| 2021 Q3 | -1.21 Million CAD | 51.53% |
| 2021 Q1 | -1.24 Million CAD | -114.48% |
| 2021 Q4 | -1.3 Million CAD | -7.88% |
| 2020 Q3 | -164.48 Thousand CAD | 83.39% |
| 2020 Q1 | -672.86 Thousand CAD | 25.54% |
| 2020 FY | -2.45 Million CAD | 44.35% |
| 2020 Q4 | -582.67 Thousand CAD | -254.24% |
| 2020 Q2 | -990.05 Thousand CAD | -47.14% |
| 2019 Q1 | -111.76 Thousand CAD | -623.91% |
| 2019 Q2 | -51.95 Thousand CAD | 53.52% |
| 2019 Q3 | -657.08 Thousand CAD | -1164.76% |
| 2019 Q4 | -903.64 Thousand CAD | -37.52% |
| 2019 FY | -4.4 Million CAD | -2869.32% |
| 2018 Q3 | -8491.00 CAD | 33.15% |
| 2018 Q2 | -12.7 Thousand CAD | 34.69% |
| 2018 FY | -148.4 Thousand CAD | -185.72% |
| 2018 Q1 | -19.44 Thousand CAD | -119.2% |
| 2018 Q4 | -15.43 Thousand CAD | -81.83% |
| 2017 Q3 | -14.6 Thousand CAD | -61.95% |
| 2017 Q2 | -9017.00 CAD | 32.29% |
| 2017 Q1 | -13.31 Thousand CAD | 5.96% |
| 2017 Q4 | -8872.00 CAD | 39.25% |
| 2017 FY | -51.93 Thousand CAD | -13.45% |
| 2016 Q2 | -10.74 Thousand CAD | 27.51% |
| 2016 FY | -45.78 Thousand CAD | 26.2% |
| 2016 Q1 | -14.81 Thousand CAD | -2.69% |
| 2016 Q3 | -7561.00 CAD | 29.61% |
| 2016 Q4 | -14.16 Thousand CAD | -87.29% |
| 2015 Q2 | -19.62 Thousand CAD | 20.35% |
| 2015 Q1 | -24.63 Thousand CAD | 18.1% |
| 2015 FY | -62.03 Thousand CAD | 42.82% |
| 2015 Q4 | -14.43 Thousand CAD | -9.59% |
| 2015 Q3 | -13.16 Thousand CAD | 32.89% |
| 2014 Q4 | -30.07 Thousand CAD | -2.26% |
| 2014 Q3 | -29.41 Thousand CAD | -20.67% |
| 2014 Q2 | -24.37 Thousand CAD | 30.61% |
| 2014 Q1 | -35.12 Thousand CAD | -26.97% |
| 2014 FY | -108.49 Thousand CAD | 20.87% |
| 2013 Q2 | -38.42 Thousand CAD | -169.19% |
| 2013 Q4 | -27.66 Thousand CAD | 22.94% |
| 2013 Q1 | -14.27 Thousand CAD | 70.42% |
| 2013 FY | -137.11 Thousand CAD | -45.12% |
| 2013 Q3 | -35.9 Thousand CAD | 6.57% |
| 2012 Q4 | -48.25 Thousand CAD | -98.49% |
| 2012 Q1 | -85.95 Thousand CAD | -1602.71% |
| 2012 Q2 | -7645.00 CAD | 91.11% |
| 2012 Q3 | -24.31 Thousand CAD | -217.99% |
| 2012 FY | -94.48 Thousand CAD | -3.83% |
| 2011 Q4 | -5048.00 CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 FY | -91 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -1.19 Million CAD | -182.076% |
| Ayurcann Holdings Corp. | -3.25 Million CAD | -3.338% |
| Blueberries Medical Corp. | -1.22 Million CAD | -173.885% |
| The BC Bud Corporation | -1.22 Million CAD | -174.577% |
| BioNxt Solutions Inc. | -6.36 Million CAD | 47.24% |
| CordovaCann Corp. | -2.51 Million CAD | -33.704% |
| Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -281.511% |
| Captor Capital Corp. | 655.2 Thousand CAD | 612.72% |
| City View Green Holdings Inc. | -996.45 Thousand CAD | -237.135% |
| 1CM Inc. | 300.79 Thousand CAD | 1216.851% |
| Global Hemp Group Inc. | -551.7 Thousand CAD | -508.907% |
| Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 13.398% |
| IM Cannabis Corp. | -12.17 Million CAD | 72.408% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -756.514% |
| Mountain Valley MD Holdings Inc. | -3.18 Million CAD | -5.442% |
| Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 719.504% |
| Ovation Science Inc. | -764 Thousand CAD | -339.706% |
| Pharmadrug Inc. | -1.33 Million CAD | -151.637% |
| Captiva Verde Wellness Corp. | -1.14 Million CAD | -194.173% |
| RAMM Pharma Corp. | -7.08 Million CAD | 52.592% |
| RIV Capital Inc. | 1.78 Million CAD | 288.704% |
| Revive Therapeutics Ltd. | -3.28 Million CAD | -2.232% |
| Red White & Bloom Brands Inc. | -8.76 Million CAD | 61.69% |
| SLANG Worldwide Inc. | -5.98 Million CAD | 43.883% |
| 1933 Industries Inc. | -9.34 Million CAD | 64.068% |
| Red Light Holland Corp. | -6.44 Million CAD | 47.888% |
| Top Strike Resources Corp. | -784.8 Thousand CAD | -328.055% |
| Xebra Brands Ltd. | -1.55 Million CAD | -116.102% |
| Adastra Holdings Ltd. | -1.79 Million CAD | -87.282% |